IP Verse

Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related Disorders - EP2282758B1

PatentPatent Analysis

EP2282758

BIOARCTIC
Application Number
EP09738534A
Filing Date
Apr 28, 2009
Status
Revoked
Sep 19, 2024
Grant Date
Nov 21, 2018
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2282758B1 was granted to Bioarctic on Nov 21, 2018 following the initial filing on Apr 28, 2009 under the application number EP09738534A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CARPMAELS & RANSFORD SPECIALITIESAug 21, 2019ADMISSIBLE
UCB BIOPHARMAAug 21, 2019ADMISSIBLE
JAMES POOLEAug 16, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents